12 percent upside?
Maybe for a large company getting just one more approval.
This is a small biotech with a large pipeline getting its first approval on a first in class treatment, and with a huge patent portfolio, with many would-bes wanting to follow in their footprints.
Relatively unknown company in the US, but that will change quickly.
12 percent slight possibility if new shorters immediately dive in. 300 percent also a possibility. It has happened before..
Either way, expect a wild roller coaster ride to follow
12 percent upside?Maybe for a large company getting just one...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.050(4.44%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.07 | $6.691M | 6.063M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29733 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 81085 | 16 |
View Market Depth
| Last trade - 15.18pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |